| Similar Articles |
|---|
 |
The Motley Fool
October 3, 2011
Brian D. Pacampara |
Emergent BioSolutions Shares Jumped: What You Need to Know Shares of biodefense specialist Emergent BioSolutions popped 13% on Monday after landing a contract with the U.S. government to supply it with 44.75 million doses of anthrax vaccine BioThrax.   |
The Motley Fool
May 22, 2007
Mike Havrilla |
An Emergent Opportunity The vaccine developer guided for revenue growth of 10% to 15% for this year. Emergent also has a strong balance sheet, with more than $67 million in cash and investments. Investors, take note. |
The Motley Fool
August 31, 2009 |
2 Stocks Hitting High Notes These stocks are reaching for the stars and hitting 52-week highs. Take a look at: Marvel Entertainment... Sinovac Biotech... |
The Motley Fool
June 2, 2009
Adam J. Wiederman |
These Stocks Can Easily Double Your Money In any market, the stocks with the most potential for outsized returns (stocks that are going to double, triple, or even increase your investment tenfold) are not found among large caps, but rather among the little guys. |
The Motley Fool
August 26, 2009 |
3 Stocks Hitting High Notes These stocks are reaching for the stars and hitting 52-week highs. Take a look at: Bed Bath & Beyond... Sinovac Biotech... Dollar Tree Stores... |
The Motley Fool
January 12, 2011
Brad Hessel |
For Market Volatility, No News Is Good News Fourth-quarter 2010 volatility is a no-show. Are things back to normal? |
The Motley Fool
February 18, 2005
Brian Gorman |
Monsanto Cottons to Emergent Monsanto's second acquisition in less than a month signals an aggressive move into cotton seeds. Investors will no doubt keep a close eye on this one. |
The Motley Fool
August 11, 2009 |
3 Stocks Hitting High Notes Tellabs... Human Genome Sciences... priceline.com... etc. |
The Motley Fool
October 26, 2006
Dan Caplinger |
Volatility: Friend or Foe? By being aware of volatility and taking steps to reduce it, while also making the most of the opportunities it brings, you can not only improve your investment returns, but also avoid the anxiety of dramatic movements in your net worth. |
